QLENX
Price
$15.67
Change
+$0.01 (+0.06%)
Updated
Dec 23 closing price
SAOSX
Price
$21.52
Change
-$0.08 (-0.37%)
Updated
Dec 23 closing price
Ad is loading...

QLENX vs SAOSX

Header iconQLENX vs SAOSX Comparison
Open Charts QLENX vs SAOSXBanner chart's image
AQR Long-Short Equity N
Price$15.67
Change+$0.01 (+0.06%)
VolumeN/A
CapitalizationN/A
NAA Opportunity Fund P
Price$21.52
Change-$0.08 (-0.37%)
VolumeN/A
CapitalizationN/A
QLENX vs SAOSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
QLENX vs. SAOSX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QLENX is a Hold and SAOSX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
QLENX has more cash in the bank: 2.21B vs. SAOSX (36.7M). QLENX pays higher dividends than SAOSX: QLENX (18.52) vs SAOSX (0.56). QLENX was incepted earlier than SAOSX: QLENX (11 years) vs SAOSX (10 years). SAOSX is a more actively managed with annual turnover of: 309.00 vs. QLENX (0.00). SAOSX has a lower initial minimum investment than QLENX: SAOSX (0) vs QLENX (2500). QLENX annual gain was more profitable for investors over the last year : 30.04 vs. SAOSX (10.19). QLENX return over 5 years is better than : 102.74 vs. SAOSX (25.34).
QLENXSAOSXQLENX / SAOSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years10 years-
Gain YTD30.44310.700285%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.21B36.7M6,025%
Annual Yield % from dividends18.520.563,300%
Returns for 1 year30.0410.19295%
Returns for 3 years87.7612.20720%
Returns for 5 years102.7425.34405%
Returns for 10 years124.94N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZG73.38-0.39
-0.53%
Zillow Group
ABUS3.19-0.02
-0.62%
Arbutus Biopharma Corp
VS2.14-0.04
-1.83%
Versus Systems
PTGX40.60-0.89
-2.15%
Protagonist Therapeutics
CXAI1.55-0.04
-2.52%
CXApp